- ►wanfang.gov.tw [DOC] RE Amori, J Lau, AG Pittas - Jama, 2007 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ... Cited by 248 - Related articles - BL Direct - All 8 versions
- ►diabetesjournals.org B Ahrén - Diabetes Care, 2007 - Am Diabetes Assoc The enzyme dipeptidyl peptidase-4 (DPP-4) prevents the inactivation of glucagon-like
peptide-1 (GLP-1). Since GLP-1–based therapy is a promising novel treatment of type 2
diabetes, the strategy to inhibit the enzyme has been explored. Several DPP-4 inhibitors ... Cited by 51 - Related articles - BL Direct - All 11 versions
G Bolli, F Dotta, E Rochotte, SE Cohen - Diabetes Obes Metab, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 49 - Related articles - All 2 versions
AJ Garber, JE Foley, MA Banerji, P Ebeling, … - Diabetes Obes …, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 37 - Related articles - All 4 versions
- ►endojournals.org BE Dunning, JE Gerich - Endocrine reviews, 2007 - Endocrine Soc The hyperglycemic activity of pancreatic extracts was encountered some 80 yr ago during efforts
to optimize methods for the purification of insulin. The hyperglycemic substance was named
"glucagon," and it was subsequently determined that glucagon is a 29-amino acid peptide ... Cited by 32 - Related articles - BL Direct - All 5 versions
J Rosenstock, JE Foley, M Rendell, M Landin- … - Diabetes Care, 2008 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A 12-week, double-blind, randomized, parallel-group
study comparing vildagliptin (50 mg qd) and placebo was conducted in 179 subjects with IGT
(2-h glucose 9.1 mmol/l, A1C 5.9%). Plasma levels of intact glucagon-like peptide 1 ... Cited by 28 - Related articles - BL Direct - All 5 versions
A Cohen, ES Horton - Current Medical Research and Opinion®, 2007 - informahealthcare.com Background: Type 2 diabetes mellitus (T2DM) is a leading cause of morbidity and mortality that
places a substantial economic and health burden on the public. Successful management of T2DM
requires strict control of glycemia as well as other risk factors to prevent disease ... Cited by 26 - Related articles - BL Direct - All 5 versions
- ►insulinjournal.com [PDF] B Ahrén - Best Practice & Research Clinical Endocrinology & …, 2007 - Elsevier Inhibition of dipeptidyl peptidase 4 (DPP-4) is a novel treatment for type-2 diabetes. DPP-4 inhibition
prevents the inactivation of glucagon-like peptide 1 (GLP-1), which increases levels of active
GLP-1. This increases insulin secretion and reduces glucagon secretion, thereby ... Cited by 26 - Related articles - All 19 versions
WA Scherbaum, A Schweizer, A Mari, PM … - Diabetes Obes …, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 24 - Related articles - All 2 versions
S Madsbad, T Krarup, CF Deacon, JJ … - Current Opinion in Clinical …, 2008 - journals.lww.com Recent findings: The injectable glucagon-like peptide-1 receptor agonists exenatide significantly
improves glycaemic control, with average reductions in haemoglobin A1c of about 1.0%, fasting
plasma glucose of about 1.4 mmol/l, and causes a weight loss of approximately 2-3 kg ... Cited by 25 - Related articles - All 2 versions
